Kannalife, Inc. (KLFE) financial statements (2021 and earlier)

Company profile

Business Address 3805 OLD EASTON ROAD
DOYLESTOWN, PA 18902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1212,88720
Cash and cash equivalents12130720
Short-term investments 2,580  
Receivables   10
Prepaid expense9   
Other undisclosed current assets01160 
Total current assets:1313,003210
Noncurrent Assets
Property, plant and equipment753  
Deposits noncurrent assets 17  
Other undisclosed noncurrent assets17   
Total noncurrent assets:9320  
TOTAL ASSETS:2233,023210
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:389284117
Accounts payable  117
Accrued liabilities243246  
Employee-related liabilities243   
Other undisclosed accounts payable and accrued liabilities(97)38  
Debt6621645 
Derivative instruments and hedges, liabilities183   
Due to related parties25  20
Other liabilities  5 
Other undisclosed current liabilities67246  
Total current liabilities:1,3275465136
Noncurrent Liabilities
Long-term debt and lease obligation37926  
Long-term debt, excluding current maturities37926  
Liabilities, other than long-term debt183   
Derivative instruments and hedges, liabilities183   
Other undisclosed noncurrent liabilities281,120  
Total noncurrent liabilities:5901,146  
Total liabilities:1,9171,6925136
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,694)1,331(49)(26)
Common stock7711
Additional paid in capital6,7956,3823535
Accumulated deficit(8,496)(5,052)(85)(62)
Other undisclosed stockholders' equity attributable to parent (6)  
Total stockholders' equity:(1,694)1,331(49)(26)
TOTAL LIABILITIES AND EQUITY:2233,023210

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues126174135
Realized investment gains 3,902  
Cost of revenue (62) (21)
Provision for loan, lease, and other losses (62)
Gross profit:126112114
Operating expenses(2,455)(1,236)(24)(46)
Other undisclosed operating income 62  
Operating loss:(2,329)(1,062)(22)(32)
Nonoperating income (expense)(1,122)2,805  
Interest and debt expense(147)   
Income (loss) from continuing operations before equity method investments, income taxes:(3,598)1,743(22)(32)
Other undisclosed income from continuing operations before income taxes147   
Income (loss) from continuing operations before income taxes:(3,451)1,743(22)(32)
Income tax expense (812)  
Net income (loss):(3,451)931(22)(32)
Net income attributable to noncontrolling interest76  
Other undisclosed net loss attributable to parent(7)   
Net income (loss) attributable to parent:(3,451)937(22)(32)
Other undisclosed net income available to common stockholders, basic7   
Net income (loss) available to common stockholders, diluted:(3,444)937(22)(32)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(3,451)931(22)(32)
Comprehensive income (loss):(3,451)931(22)(32)
Comprehensive income, net of tax, attributable to noncontrolling interest76  
Comprehensive income (loss), net of tax, attributable to parent:(3,444)937(22)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: